Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 10, 2010, Pages 1175-1185

  Abate Daga, Daniel ^a,b   Garcia Rodríguez, Laura ^a,b   Sumoy, Lauro ^c   Fillat, Cristina ^a,b  

^a Barcelona Biomedical Research Park   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c Institute of Predictive and Personalized Medicine of Cancer   (Spain)

Author keywords

Cell cycle; Chk1; Ganciclovir; Pancreatic cancer; Thymidine kinase

Indexed keywords

7 HYDROXYSTAUROSPORINE; COMPLEMENTARY DNA; GANCICLOVIR; THYMIDINE KINASE; ANTIVIRUS AGENT; ATM PROTEIN; ATM PROTEIN, HUMAN; ATR PROTEIN, HUMAN; CCNE1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CHEK2 PROTEIN, HUMAN; CYCLIN E; DNA BINDING PROTEIN; GADD45A PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; GENE EXPRESSION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; SUICIDE GENE THERAPY; CELL CYCLE; CELL SURVIVAL; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIVIRAL AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN E; DNA-BINDING PROTEINS; GANCICLOVIR; GENE EXPRESSION PROFILING; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; PANCREATIC NEOPLASMS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYMIDINE KINASE; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CHECKPOINT KINASE 2;

SIMPLEXVIRUS;

EID: 77955652996     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.06.009     Document Type: Article

References (34)

1. Fillat C., Carrio M., Cascante A., Sangro B. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. Curr. Gene Ther. 2003, 3:13-26.
2. Immonen A., Vapalahti M., Tyynela K., Hurskainen H., Sandmair A., Vanninen R., Langford G., Murray N., Yla-Herttuala S. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol. Ther. 2004, 10:967-972.
3. Tomicic M.T., Thust R., Kaina B. Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation. Oncogene 2002, 21:2141-2153.
4. Beltinger C., Fulda S., Kammertoens T., Meyer E., Uckert W., Debatin K.M. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc. Natl. Acad. Sci. USA 1999, 96:8699-8704.
5. Fischer U., Steffens S., Frank S., Rainov N.G., Schulze-Osthoff K., Kramm C.M. Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. Oncogene 2005, 24:1231-1243.
6. Glaser T., Castro M.G., Lowenstein P.R., Weller M. Death receptor-independent cytochrome c release and caspase activation mediate thymidine kinase plus ganciclovir-mediated cytotoxicity in LN-18 and LN-229 human malignant glioma cells. Gene Ther. 2001, 8:469-476.
7. Hamel W., Magnelli L., Chiarugi V.P., Israel M.A. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res. 1996, 56:2697-2702.
8. Reyes G., Villanueva A., Garcia C., Sancho F.J., Piulats J., Lluis F., Capella G. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice. Cancer Res. 1996, 56:5713-5719.
9. Huch M., Abate-Daga D., Roig J.M., Gonzalez J.R., Fabregat J., Sosnowski B., Mazo A., Fillat C. Targeting the CYP2B 1/cyclophosphamide suicide system to fibroblast growth factor receptors results in a potent antitumoral response in pancreatic cancer models. Hum. Gene Ther. 2006, 17:1187-1200.
10. Cascante A., Abate-Daga D., Garcia-Rodriguez L., Gonzalez J.R., Alemany R., Fillat C. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model. Gene Ther. 2007, 14:1471-1480.
11. Carrio M., Romagosa A., Mercade E., Mazo A., Nadal M., Gomez-Foix A.M., Fillat C. Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene. Gene Ther. 1999, 6:547-553.
12. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30:e36.
13. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
14. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y., Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80.
15. Wettenhall J.M., Smyth G.K. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 2004, 20:3705-3706.
16. Brunet A., Kanai F., Stehn J., Xu J., Sarbassova D., Frangioni J.V., Dalal S.N., DeCaprio J.A., Greenberg M.E., Yaffe M.B. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 2002, 156:817-828.
17. Zuco V., Zanchi C., Cassinelli G., Lanzi C., Supino R., Pisano C., Zanier R., Giordano V., Garattini E., Zunino F. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid. Cell Death Differ. 2004, 11:280-289.
18. Chou T.C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 1984, 22:27-55.
19. Bartek J., Lukas C., Lukas J. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 2004, 5:792-804.
20. Ilsley D.D., Lee S.H., Miller W.H., Kuchta R.D. Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action. Biochemistry 1995, 34:2504-2510.
21. Parsels L.A., Morgan M.A., Tanska D.M., Parsels J.D., Palmer B.D., Booth R.J., Denny W.A., Canman C.E., Kraker A.J., Lawrence T.S., Maybaum J. Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells. Mol. Cancer Ther. 2009, 8:45-54.
22. Garin M.I., Garrett E., Tiberghien P., Apperley J.F., Chalmers D., Melo J.V., Ferrand C. Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene. Blood 2001, 97:122-129.
23. Yang L., Hwang R., Chiang Y., Gordon E.M., Anderson W.F., Parekh D. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Clin. Cancer Res. 1998, 4:731-741.
24. Moroy T., Geisen C. Cyclin E. Int. J. Biochem. Cell Biol. 2004, 36:1424-1439.
25. Mazumder S., DuPree E.L., Almasan A. A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy. Curr. Cancer Drug Targets 2004, 4:65-75.
26. Mazumder S., Plesca D., Kinter M., Almasan A. Interaction of a cyclin E fragment with Ku70 regulates Bax-mediated apoptosis. Mol. Cell. Biol. 2007, 27:3511-3520.
27. Hildesheim J., Fornace A.J. Gadd45a: an elusive yet attractive candidate gene in pancreatic cancer. Clin. Cancer Res. 2002, 8:2475-2479.
28. Missiaglia E., Donadelli M., Palmieri M., Crnogorac-Jurcevic T., Scarpa A., Lemoine N.R. Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway. Oncogene 2005, 24:199-211.
29. Li Y., Qian H., Li X., Wang H., Yu J., Liu Y., Zhang X., Liang X., Fu M., Zhan Q., Lin C. Adenoviral-mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell. J. Gene Med. 2009, 11:3-13.
30. Rubsam L.Z., Davidson B.L., Shewach D.S. Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killing. Cancer Res. 1998, 58:3873-3882.
31. Tse A.N., Carvajal R., Schwartz G.K. Targeting checkpoint kinase 1 in cancer therapeutics. Clin. Cancer Res. 2007, 13:1955-1960.
32. Zhou B.B., Bartek J. Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nat. Rev. Cancer 2004, 4:216-225.
33. Tao Z.F., Lin N.H. Chk1 inhibitors for novel cancer treatment. Anticancer Agents Med. Chem. 2006, 6:377-388.
34. McMasters R.A., Wilbert T.N., Jones K.E., Pitlyk K., Saylors R.L., Moyer M.P., Chambers T.C., Drake R.R. Two-drug combinations that increase apoptosis and modulate bak and bcl-X(L) expression in human colon tumor cell lines transduced with herpes simplex virus thymidine kinase. Cancer Gene Ther. 2000, 7:563-573.